Menin Inhibitor therapy (Bala Therapeutics)

N/A

Report date: 2025/10/20 15:40:09
NME

Base Information

Drug NameMenin Inhibitor therapy (Bala Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMenin inhibitors
TargetsMenin
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBala Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLomond Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A